Q-omics provides the consensus-scored MIR8068 profile across patient tissues and cancer cell-line models. MIR8068 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, MIR8068 is differentially expressed in 1, with the highest sampling consensus in ESCA. Additionally, MIR8068 RNA expression shows 5,350 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight KIRC, ESCA, and COAD as cancer lineages where MIR8068 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR8068 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR8068 survival associations across molecular data types. MIR8068 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR8068 RNA expression–survival associations across cancer types. High MIR8068 expression shows unfavorable associations in KIRC, ACC, THCA, PAAD, DLBC and SKCM. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for MIR8068 RNA expression.
This table summarizes MIR8068 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in ESCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR8068. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR8068 shows higher tumor expression in ESCA. The ESCA box plot shows higher MIR8068 RNA expression in tumor versus normal tissue (log2 FC = +0.679, t-test p = .017).
This table shows molecular features associated with MIR8068 in patient tissues and cancer cell lines. In patient samples, MIR8068 shows the broadest associations at the RNA and protein expression levels, with COAD recurring as the lineage with the largest associated feature set.
